住宅房产ETF-iShares REZ 深 沪
等待开盘 10-03 09:30:00 美东时间
84.21
-0.844
-0.99%
华盛通- 最 高84.85
- 今 开84.85
- 成交量 4.61万股
- 最 低 83.8493
- 昨 收 85.054
- 总市值 8.08亿
- 52周最高 88.4736
- 市盈率 静 --
- 换手率 0.48%
- 52周最低 72.2381
- 委 比 14.29%
- 总股本 960.00万
- 历史最高 92.6962
- 量 比 1.07
- 振 幅 1.18%
- 历史最低 26.8699
- 每 手 1
- 风险率 2.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Is Nektar Therapeutics Stock Trading Lower On Thursday?
Nektar reported Phase 2b results showing rezpegaldesleukin improved eczema severity scores and met primary and key secondary endpoints in patients.
09-19 02:31
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
Rezolute, Inc. reported financial results and business updates for the fiscal year ended June 30, 2025, highlighting progress in their Phase 3 trials for ersodetug, a treatment for hypoglycemia caused by hyperinsulinism. The company achieved enrollment in the sunRIZE trial for congenital hyperinsulinism and aligned with the FDA on a streamlined clinical path for tumor hyperinsulinism. Financially, the company held $167.9 million in cash and saw i...
09-17 20:05
REZ Group Receives Approval for Full-Scale Gold Production Expansion
Resources & Energy Group Limited ( ($AU:REZ) ) has shared an update. Resour...
09-09 10:37
What's Going On With Nektar Therapeutics Stock On Thursday?
Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results.
09-05 02:52
Rezolute to Participate in Upcoming Investor Conferences
Rezolute, Inc. announced that its management will participate in three upcoming investor conferences in September 2025: the Cantor Global Healthcare Conference (September 3-5), the H.C. Wainwright 27th Annual Global Investment Conference (September 8-10), and the Morgan Stanley 23rd Annual Global Healthcare Conference (September 8-10). Management will engage in Fireside Chats and one-on-one investor meetings at these events. The Company focuses o...
08-27 11:30
Home sales falling through at highest rate in years - Redfin
Home purchases are getting canceled at the highest rate in years as high prices, elevated mortgage rates and economic uncertainty deter buyers, according to Redfin's analysis of MLS pending-sales data...
08-25 17:17
Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio
CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"),
08-07 19:14
Nektar Therapeutics launches proposed public offering
Nektar Therapeutics (NASDAQ:NKTR) has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase shares of its common stock. NKTR -2.45% after hours to...
07-01 04:10
Nektar Therapeutics Announces Proposed Public Offering
SAN FRANCISCO, June 30, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of imm...
07-01 04:02
Nektar Therapeutics surge continues as stock up another 25%
Nektar Therapeutics (NASDAQ:NKTR), which closed Tuesday up ~156% after its lead asset, rezpegaldesleukin, met its main goal in a mid-stage trial for atopic dermatitis, also known as eczema, is up anot...
06-26 02:14
